Friday, April 12, 2019 2:28:08 PM
There is an adjustment clause in the warrant agreement, filed with the Draper Oakwood (DOTA) S-1 registration form with the SEC on 8/25/2017.
For clarity, I'm just posting the applicable parts of the Warrant Agreement, parts 4.2 and 4.4:
4. Adjustments.
4.2. Aggregation of Shares. If after the date hereof, the number of outstanding shares of Common Stock is decreased by a consolidation, combination, reverse stock split or reclassification of shares of Common Stock or other similar event, then, on the effective date of such consolidation, combination, reverse stock split, reclassification or similar event, the number of shares of Common Stock issuable on exercise of each Warrant shall be decreased in proportion to such decrease in outstanding shares of Common Stock.
4.4 Adjustments in Exercise Price. Whenever the number of shares of Common Stock purchasable upon the exercise of the Warrants is adjusted, as provided in Sections 4.1 and 4.2 above, the Warrant Price shall be adjusted (to the nearest cent) by multiplying such Warrant Price immediately prior to such adjustment by a fraction (x) the numerator of which shall be the number of shares of Common Stock purchasable upon the exercise of the Warrants immediately prior to such adjustment, and (y) the denominator of which shall be the number of shares of Common Stock so purchasable immediately thereafter.
https://www.sec.gov/Archives/edgar/data/1705771/000121390017009194/fs12017ex4-6_draperoak.htm
Part 4.2 means that after the reverse split, it requires 8 warrants to buy one share of common.
Part 4.4 means that after the reverse split, the cost of that share of common will be $92 per share ( $11.50 times (8 divided by 1 )).
I'm sure this is not what you are all hoping for ... however, this is apparently the correct information, as it was recently confirmed in the annual report released by Reebonz.
Here are the new warrant terms and data, as posted in the latest 20-F filing (Annual Report for foreign companies) with the SEC on 4/1/2019, and the amended 20-F/A filed 4/9/2019:
"We have outstanding warrants to purchase 385,715 ordinary shares, which are exercisable at $92.00 (which gives effect to the 1-for-8 reverse split effectuated on March 11, 2019). The warrants are exercisable until December 19, 2023. We may redeem the outstanding warrants at a price of $0.08 per warrant, upon a minimum of 30 days’ prior written notice of redemption, if among other circumstances, the last sale price of our ordinary shares equals or exceeds $192.00 for any 20 trading days within a 30-trading day period ending on the third trading day prior to the date on which we send notice of redemption to the warrant holders."
https://www.sec.gov/Archives/edgar/data/1752108/000121390019006031/f20f2018a1_reebonzholding.htm
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM